- ICH GCP
- Registro de ensayos clínicos de EE. UU.
- Ensayo clínico NCT00927264
PRIDE: Preventing Respiratory Illnesses During Childhood Study (PRIDE)
A+ Head Start Intervention for Smoke Free Homes
Descripción general del estudio
Estado
Condiciones
Descripción detallada
About 90% of nonsmoking people in the US are exposed to ETS. More than 50 chemicals identified in ETS have been found to cause cancer and exposure has been linked to heart disease in adults and SIDS, ear infections and numerous respiratory problems, including asthma in children. In 2007, the Environmental Protection Agency and the Office of Head Start-a national program that provides economically disadvantaged children services to enhance their social and cognitive development-announced a new initiative to promote smoke-free homes for children in Head Start programs. Because Head Start reaches high-risk, low-income preschool children, it offers a timely intervention for reducing children's exposure to ETS. Head Start also attempts to engage parents, which is an important component of reducing household ETS exposure among children. This study will determine the effectiveness of a home-delivered, motivational interviewing-based program in reducing ETS exposure and improving lung health among children who are enrolled in the Baltimore City Head Start program and whose households include a smoker.
Participation in this study will last 1 year. First, all participating families will be visited at home by a study staff person who will attach special filters that will track the amount of nicotine in the various rooms of the house. During this initial visit, the participating children will undergo weight and height measurements and saliva sampling. About a week later, the filters will be collected, a 2nd saliva samples will be taken and parents will be interviewed about their family and child's health. Families will then be randomly assigned to one of two groups. Both groups will received educational information about reducing tobacco smoke exposure. One group will also receive the home-delivered, motivational interviewing-based program aimed to reduce ETS. This program will consist of 2 home visits and 2 phone calls, both led by health counselor who will teach participants how to reduce their child's exposure to tobacco smoke. The home visits will occur during Weeks 1 & 2 and the phone calls will occur during Weeks 3 & 6. Follow-up visits for all participating families will occur at Months 3,6 and 12 and will involve repeat filter testing, saliva monitoring and interviews.
Tipo de estudio
Inscripción (Actual)
Fase
- No aplica
Contactos y Ubicaciones
Ubicaciones de estudio
-
-
Maryland
-
Baltimore, Maryland, Estados Unidos, 21206
- Johns Hopkins University
-
-
Criterios de participación
Criterio de elegibilidad
Edades elegibles para estudiar
Acepta Voluntarios Saludables
Géneros elegibles para el estudio
Descripción
Inclusion Criteria:
- Child enrolled in Baltimore City Head Start
- Smoker living in the home with child
Exclusion Criteria:
- No smoker in home with child
- Does not speak English
- Is enrolled in other respiratory research study
Plan de estudios
¿Cómo está diseñado el estudio?
Detalles de diseño
- Propósito principal: Prevención
- Asignación: Aleatorizado
- Modelo Intervencionista: Asignación factorial
- Enmascaramiento: Único
Armas e Intervenciones
Grupo de participantes/brazo |
Intervención / Tratamiento |
|---|---|
|
Experimental: Behavioral
Motivational Interviewing Intervention Plus Education Caregivers will receive a home-based motivational interviewing intervention for ETS reduction plus an educational program for ETS reduction. |
The intervention is designed to motivate caregivers to reduce a child's ETS exposure by establishing a complete home and car smoking ban and by considering smoking cessation.
Caregivers will receive 2 home visits & 2 telephone session, both with a health counselor.
Caregivers will be provided with feedback on air nicotine levels and child salivary cotinine levels.
The main target for the intervention will be the primary caregiver of the child because the primary caregiver is ultimately responsible for protecting the child from ETS exposure.
Any and all household members may participate in the intervention visits but are not required to do so.
|
|
Comparador activo: Education Only
Caregivers will receive only educational program for ETS reduction.
|
An Environmental Protection Agency-based educational program that will consist of information about reducing tobacco smoke exposure.
|
¿Qué mide el estudio?
Medidas de resultado primarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Air Nicotine Levels
Periodo de tiempo: Measured at Baseline, 3, 6 and 12 months
|
Air nicotine levels were an indicator of child's exposure to environmental tobacco smoke (ETS)
|
Measured at Baseline, 3, 6 and 12 months
|
Medidas de resultado secundarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
ETS Reduction, as Measured by Child's Cotinine Levels
Periodo de tiempo: Measured at Baseline, 3, 6 and 12 months
|
Child salivary cotinine will be a measure to evaluate environmental tobacco smoke (ETS) reduction
|
Measured at Baseline, 3, 6 and 12 months
|
|
Respiratory Function of Child by Self Report of Parent
Periodo de tiempo: Measured at Baseline, 3, 6, and 12 months
|
Number of cold infections child experienced in previous 3 months, reported by caregiver
|
Measured at Baseline, 3, 6, and 12 months
|
|
Health Care Utilization by Child- Self Report From Parent/Caregiver
Periodo de tiempo: Measured at baseline and 3, 6 and 12 months
|
Parent caregiver reported urgent care visits, number of hospitalizations, and number of emergency department visits in the 12 months prior for child enrolled in study
|
Measured at baseline and 3, 6 and 12 months
|
|
Number of Participants Who Report Endorsing a Home Smoking Ban
Periodo de tiempo: Measured at baseline, 3, 6 and 12 months
|
Number of participants endorsing presence of home smoking ban
|
Measured at baseline, 3, 6 and 12 months
|
Colaboradores e Investigadores
Patrocinador
Colaboradores
Investigadores
- Investigador principal: Cynthia S Rand, PhD, Johns Hopkins University
Publicaciones y enlaces útiles
Fechas de registro del estudio
Fechas importantes del estudio
Inicio del estudio
Finalización primaria (Actual)
Finalización del estudio (Actual)
Fechas de registro del estudio
Enviado por primera vez
Primero enviado que cumplió con los criterios de control de calidad
Publicado por primera vez (Estimar)
Actualizaciones de registros de estudio
Última actualización publicada (Actual)
Última actualización enviada que cumplió con los criterios de control de calidad
Última verificación
Más información
Términos relacionados con este estudio
Palabras clave
Otros números de identificación del estudio
- 664
- R18HL092901-01 (Subvención/contrato del NIH de EE. UU.)
Plan de datos de participantes individuales (IPD)
¿Planea compartir datos de participantes individuales (IPD)?
Descripción del plan IPD
Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .